News | July 10, 2014

Interventional Cardiology Practice Expands to Accommodate Younger Patients Seeking Prevention

Orlando Heart Specialists opens 8th location in Dr. Phillips/Windermere Area

July 10, 2014 — Orlando Heart Specialists (OHS) has added an 8th location in southwest Orlando, Fla. According to CEO Kishore Ranadive, the interventional cardiology practice is expanding rapidly to accommodate the growing number of patients wisely seeking to prevent heart problems, rather than waiting until treatment is necessary. The new OHS state-of-the art office in the Dr. Phillips/Windermere area is located at 6735 Conroy Rd.

The additional location is a significant business milestone for OHS, making it among the fastest growing independent medical practices in the region and adding a higher level of convenience for its growing patient base.

Founded in 1997, OHS has grown to become the leading cardiology group in this region, earning national respect through its focus on preventive care and superior patient outcomes. One of six practices nationwide, and the only one in Florida, to achieve certification by the National Committee for Quality Assurance (NCQA), OHS also received the prestigious Bridges to Excellence distinction from the American College of Cardiology for delivering superior patient care.

“This is a proud moment for OHS. Now residents of the Dr. Phillips and Windermere areas will experience why we earn the highest patient satisfaction rates by providing the most positive and caring patient experience possible,” he said.

In addition to the new medical office, OHS also serves patients at its facilities in Altamonte Springs, Orlando, Oviedo, Lake Mary, downtown Orlando, Lake Nona and Apopka. OHS is comprised of board certified cardiovascular specialists dedicated to utilizing the latest technological advances and critical thinking methods in the areas of prevention, intervention, and treatment of heart and vascular disease to help improve the quality of life for their patients. 

For more information: www.OrlandoCardiology.com

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init